Idiopathic pneumonia syndrome (IPS) is a rare complication following stem cell transplant
(SCT) and its incidence among pediatric SCT recipients is not known. To assess the …

Background Idiopathic pneumonia syndrome (IPS) is a severe complication that can occur
after hematopoietic stem cell transplantation (HSCT) and is often associated with a fatal …

Idiopathic pneumonia syndrome is a rare complication following hematopoietic stem cell
transplantation (HSCT), defined by diffuse lung injury with no identified etiology, with an …

Idiopathic pneumonia syndrome (IPS) is a critical complication following allogeneic
hematopoietic SCT (HSCT); however, few reports have analyzed the risk factors for IPS in …

We retrospectively analyzed 23 cases with early‐onset idiopathic pneumonia syndrome
(IPS) of 192 patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) …

Allogeneic hematopoietic stem cell transplantation (SCT) is the only curative therapeutic
option for a number of malignant and non‐malignant conditions, but the success of this …

Our current knowledge of idiopathic pneumonia syndrome (IPS) predates improved
specificity in the diagnosis of IPS and advances in hematopoietic cell transplantation (HCT) …

Rationale: Acute lung dysfunction of noninfectious etiology, known as idiopathic pneumonia
syndrome (IPS), is a severe complication following hematopoietic stem cell transplantation …

Background. The aim of our study was to describe the incidence, clinical course, and risk
factors for the idiopathic pneumonia syndrome (IPS), compared with those previously …

Purpose Pulmonary complications, especially idiopathic pneumonitis syndrome (IPS), are
potentially life altering or fatal sequelae of hematopoietic cell transplantation (HCT). Total …